CareLit · DOI-Nachweis · Klinische Pädiatrie
Parvovirus H-1 prolongs response to antineoplastc treatment with TMZ in pediatric high-grade glioma
DOI 10.1055/s-0036-1593555
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Lacroix, R Josupeit, D Sorrentino, C Geiss, P Johann, B Leuchs, O Witt, C Dinsart, J Rommelaere
ZeitschriftKlinische Pädiatrie
Ausgabe11/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Immunotherapeutic approaches have recently entered clinical routine in oncology. Oncolytic viruses such as Parvovirus H-1 (H-1PV) combine direct cytotoxic effects with enhanced anti-tumor immune responses. Here, we characterized the cytotoxic effects induced by the oncolytic parvovirus H-1 in conventional pediatric high-grade glioma (HGG) cell culture models and the combinatorial effects in simultaneous TMZ treatmen…
Zitieren
Zitierempfehlung
J Lacroix, R Josupeit, D Sorrentino, C Geiss, P Johann, B Leuchs, O Witt, C Dinsart, J Rommelaere (2016) Parvovirus H-1 prolongs response to antineoplastc treatment with TMZ in pediatric high-grade glioma. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0036-1593555
Mit CareLit weiterarbeiten